Wen L, Kim S S, Tinn T T, Huang J K, Krishnamoorthi R, Gong Y X, Lwin Y N, Kyin S
Department of Chemistry, Western Illinois University, Macomb 61455.
Protein Expr Purif. 1993 Jun;4(3):215-22. doi: 10.1006/prep.1993.1028.
The gene encoding for a pumpkin (Curcubita maxima) trypsin inhibitor CMTI-V was synthesized chemically. The synthetic gene was prepared from four overlapping oligonucleotides by overlapping extension. The synthetic gene was amplified by polymerase chain reaction, cloned into a T7 expression vector and expressed in Escherichia coli as a fusion protein. The clone, namely 70-1, encoded a fusion protein containing 7 amino acid residues of the N-terminus of the bacterial protein rho 10 and the entire 68 residues of CMTI-V. The wild-type fusion protein constituted approximately 15% of the total bacterial protein mass and was purified to homogeneity in a single step by antibody affinity chromatography. The wild-type fusion protein possesses inhibitory activity toward trypsin and beta-Factor XIIa, but to a lesser extent when compared to the natural CMTI-V. A mutant, T43A, in which threonine at position 43 (P2 position) was replaced by alanine, was constructed. This mutant showed considerably lower specific inhibitory activity toward both trypsin and beta-Factor XIIa.
编码南瓜(笋瓜)胰蛋白酶抑制剂CMTI-V的基因通过化学方法合成。合成基因由四个重叠的寡核苷酸通过重叠延伸制备而成。合成基因通过聚合酶链反应进行扩增,克隆到T7表达载体中,并在大肠杆菌中作为融合蛋白表达。该克隆体,即70-1,编码一种融合蛋白,其包含细菌蛋白rho 10 N端的7个氨基酸残基以及CMTI-V的完整68个残基。野生型融合蛋白约占细菌总蛋白质量的15%,并通过抗体亲和层析一步纯化至均一。野生型融合蛋白对胰蛋白酶和β-因子XIIa具有抑制活性,但与天然CMTI-V相比活性较低。构建了一个突变体T43A,其中第43位(P2位)的苏氨酸被丙氨酸取代。该突变体对胰蛋白酶和β-因子XIIa的特异性抑制活性均显著降低。